No products in the cart.
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](data:image/svg+xml;nitro-empty-id=NzEzOjExMjI=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMSAxIiB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy
1. A new AI workflow utilizing large language models can predict with 99% accuracy which ulcerative colitis patients will remain...
Oncology
Reports of high-impact oncology studies by medical professionals
Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma
1. Penpulimab and lenalidomide in combination with rituximab, gemcitabine, and oxaliplatin (R-GemOx regimen) is safe, tolerable, and shows antitumour activity...
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](data:image/svg+xml;nitro-empty-id=NzQxOjExNzQ=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMSAxIiB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]
Medtronic Stealth AXiS system integrates AI-robotics for spine care The FDA recently issued a landmark clearance for a surgical platform...
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia
1. Glucagon-like peptide-1 receptor agonists (GLP-1RA) in combination with progestins are significantly more effective at reducing endometrial cancer (EC) risk...
Early menarche and later menopause are associated with increased ovarian cancer risk
1. Across the premenopausal and postmenopausal groups, early menarche, later menopause, and longer reproductive span were associated with higher ovarian...
An ultrasound test may more reliably detect ovarian cancer in premenopausal women than the Risk of Malignancy Index
1. This cohort study found that the IOTA ADNEX ultrasound model at a 10% risk threshold detected more ovarian cancers...
Human papillomavirus vaccination may allow longer cervical cancer screening intervals
1. In this individual-based modeling study, fewer cervical cancer screens for HPV-vaccinated women were the most cost-effective strategy. 2. Fewer...
Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer
1. This randomized controlled trial found that, in patients with hormone-receptor-positive, HER2-positive metastatic breast cancer, the addition of palbociclib to...
Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer
1. Among patients with previously untreated programmed death-ligand 1 positive, triple-negative breast cancer, first-line sacituzumab govitecan plus pembrolizumab significantly prolonged...
AstraZeneca moves to own multimodal oncology AI with Modella
1. AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven trial strategy....
